[KANAMYCIN AEROSOL THERAPY IN 200 CASES OF BRONCHOPULMONARY SUPPURATIONS].
This paper describes the results obtained in 200 patients with bronchopulmonary suppurative diseases who received kanamycin aerosol therapy under intermittent positive pressure and in whom bacterial sensitivity study (antibiogram) was favourable.This method of treatment was well tolerated and was practically free of side effects. In most cases the improvement was rapid, was maintained and was often life-saving.The first series contained nine patients with pulmonary tuberculosis and a constant finding of sputum positive for Koch bacillus; four of these became negative after eight weeks of treatment. This suggested that kanamycin aerosol therapy had some effect on the Koch bacillus and that the study should be continued with a much larger group of patients with tuberculous suppurative pulmonary diseases to determine the efficacy of this antibiotic.
D000336:Aerosols; D001987:Bronchiectasis; D001991:Bronchitis; D003141:Communicable Diseases; D006801:Humans; D007612:Kanamycin; D008169:Lung Abscess; D008171:Lung Diseases; D011175:Positive-Pressure Respiration; D011656:Pulmonary Emphysema; D013183:Sputum; D013492:Suppuration; D014397:Tuberculosis, Pulmonary
D000336:Aerosols; D007612:Kanamycin
AEROSOLS; BRONCHIECTASIS; BRONCHITIS; KANAMYCIN; LUNG ABSCESS; POSITIVE-PRESSURE RESPIRATION; PULMONARY EMPHYSEMA; SUPPURATION; TUBERCULOSIS, PULMONARY